A Clinical Isolate of Candida albicans with Mutations in ERG11 (Encoding Sterol 14α-Demethylase) and ERG5 (Encoding C22 Desaturase) Is Cross Resistant to Azoles and Amphotericin B
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
A clinical isolate of Candida albicans was identified as an erg5 (encoding sterol C22 desaturase) mutant in which ergosterol was not detectable and ergosta 5,7-dienol comprised >80% of the total sterol fraction. The mutant isolate (CA108) was resistant to fluconazole, voriconazole, itraconazole, ketoconazole, and clotrimazole (MIC values, 64, 8, 2, 1, and 2 μg ml −1 , respectively); azole resistance could not be fully explained by the activity of multidrug resistance pumps. When susceptibility tests were performed in the presence of a multidrug efflux inhibitor (tacrolimus; FK506), CA108 remained resistant to azole concentrations higher than suggested clinical breakpoints for C. albicans (efflux-inhibited MIC values, 16 and 4 μg ml −1 for fluconazole and voriconazole, respectively). Gene sequencing revealed that CA108 was an erg11 erg5 double mutant harboring a single amino acid substitution (A114S) in sterol 14α-demethylase (Erg11p) and sequence repetition (10 duplicated amino acids), which nullified C22 desaturase (Erg5p) function. Owing to a lack of ergosterol, CA108 was also resistant to amphotericin B (MIC, 2 μg ml −1 ). This constitutes the first report of a C. albicans erg5 mutant isolated from the clinic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Interestingly, the direct target gene of azoles, ERG11 , can only be disrupted in the ERG3 -de fi cient strains or when strains are cultured in media with nystatin or amphotericin B, as the sterols with a C14-methyl group or diols especially for 14-methylergosta-8,24(28)-dien-3 b ,6 a -diol accumulated by ERG3 is lethal in C. albicans .”
From The synthesis, regulation, and functions of sterols in Candida albicans: Well-known but still lots to learn (2016) · cites this paper as [32]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“By using the technology of gene disruption and controlled gene expression, ERG1 , ERG7 , ERG9 , ERG25 , ERG26 , and ERG27 have been proved to be essential, while ERG2 , ERG3 , ERG5 , ERG6 , and ERG24 are considered to be non-essential in ergosterol biosynthesis.”
From The synthesis, regulation, and functions of sterols in Candida albicans: Well-known but still lots to learn (2016) · cites this paper as [29]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lower abundance of the enzyme has been observed in polyene-resistant species, which has been attributed to mutations in ERG2 [61,112], ERG3 [51], ERG5 [60], ERG6 [113], and ERG11 [60] genes, which encode enzymes involved in ergosterol synthesis.”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [60]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“there is a report of mutations in other ergosterol biosynthesis genes, such as ERG5, conferring azole resistance in C. albicans, this report is isolated.”
From Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans (2020) · cites this paper as [129]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Acquired resistance is also rare, and involves reduced ergosterol biosynthesis and the production of alternative sterols to which amphotericin B has low affinity.”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [64]
Experimental — accuracy not yet measured
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815 · cited 1×
“There has been an increase in research surrounding the potential importance of drug efflux transporters (26, 30) and changes in sterol 14 -demethylase (ERG11 [CYP51]), the target of azole antifungals (10, 12, 13, 14, 25).”
BackgroundSaville, S. P., Lazzell, A. L., Monteagudo, C., & Lopez-Ribot, J. L. (2003) · Eukaryotic Cell · doi:10.1128/ec.2.5.1053-1060.2003 · Cited by 655 · cited 4×
“(B) Sterol intermediates that accumulate with classical azole inhibition of Erg11p; here, the end product is fungistatic 14 -methyl ergosta 8,24(28)-dien-3 ,6 -diol.”
BackgroundInfluentialWhite, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1482 · Cited by 612 · cited 1×
“Several mechanisms can contribute to azole resistance in pathogenic fungi, such as Candida albicans (4, 11, 14, 32, 33).”
BackgroundSanglard, D., Ischer, F., Koymans, L., & Bille, J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.241 · Cited by 465 · cited 2×
“There has been an increase in research surrounding the potential importance of drug efflux transporters (26, 30) and changes in sterol 14 -demethylase (ERG11 [CYP51]), the target of azole antifungals (10, 12, 13, 14, 25).”
BackgroundBaillie, G. S. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.3.397 · Cited by 389 · cited 1×
“Biofilm formation (2) and the possibility for azole sequestration mechanisms (15) have also attracted attention.”
BackgroundKelly, S. L., Lamb, D. C., Kelly, D. E., Manning, N. J., Loeffler, J., Hebart, H., Schumacher, U., & Einsele, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01360-9 · Cited by 351 · cited 2×
“Nonetheless, viable erg3 mutants lacking functional sterol (5,6)-desaturase (encoded by ERG3), and thus ergosterol, have been isolated from the clinic (8, 9, 21).”
BackgroundSelf-citationFranz, R., Kelly, S. L., Lamb, D. C., Kelly, D. E., Ruhnke, M., & Morschhäuser, J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3065 · Cited by 339 · cited 1×
“Several mechanisms can contribute to azole resistance in pathogenic fungi, such as Candida albicans (4, 11, 14, 32, 33).”
BackgroundSelf-citationSanguinetti, M., Posteraro, B., Fiori, B., Ranno, S., Torelli, R., & Fadda, G. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.668-679.2005 · Cited by 319 · cited 1×
“Values above the suggested clinical breakpoints (27) are in boldface.”
BackgroundWhite, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1488 · Cited by 292 · cited 2×
“Several mechanisms can contribute to azole resistance in pathogenic fungi, such as Candida albicans (4, 11, 14, 32, 33).”
Background
Cited by
Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801
Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment
Arendrup, M. C., & Patterson, T. F. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix131 · Cited by 707
Pathogenesis of Candida albicans biofilm
Tsui, C., Kong, E. F., & Jabra-Rizk, M. A. (2016) · Pathogens and Disease · doi:10.1093/femspd/ftw018 · Cited by 481
Emerging Threats in Antifungal-Resistant Fungal Pathogens
Sanglard, D. (2016) · Frontiers in Medicine · doi:10.3389/fmed.2016.00011 · Cited by 416
Biofilm of Candida albicans : formation, regulation and resistance
Pereira, R., Santos Fontenelle, R. O., Brito, E. H. S., & Morais, S. M. (2021) · Journal of Applied Microbiology · doi:10.1111/jam.14949 · Cited by 368
Amphotericin B and Other Polyenes—Discovery, Clinical Use, Mode of Action and Drug Resistance
Carolus, H., Pierson, S., Lagrou, K., & Van Dijck, P. (2020) · Journal of Fungi · doi:10.3390/jof6040321 · Cited by 349
“albicans is associated with a substitution in ERG11 and loss of function of ERG5 (C-22 sterol desaturase), again associated with an alternate membrane sterol composition [20,59].”
Backgroundde Oliveira Santos, G. C., Vasconcelos, C. C., Lopes, A. J. O., de Sousa Cartágenes, M. D. S., Filho, A. K. D. B., do Nascimento, F. R. F., Ramos, R. M., Pires, E. R. R. B., de Andrade, M. S., Rocha, F. M. G., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01351 · Cited by 350
“Most of them were related to FLZ resistance (Sanglard et al., 2003; Lo et al., 2005; Martel et al., 2010).”
BackgroundFitness Trade-offs Restrict the Evolution of Resistance to Amphotericin B
Vincent, B. M., Lancaster, A. K., Scherz-Shouval, R., Whitesell, L., & Lindquist, S. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001692 · Cited by 322
Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens
Ksiezopolska, E., & Gabaldón, T. (2018) · Genes · doi:10.3390/genes9090461 · Cited by 230
“However, overexpression of ERG11 [93] and the ABC transporter, ABC1, has also been related to fluconazole resistance in this species [94].”
BackgroundInfluentialLipid Systems for the Delivery of Amphotericin B in Antifungal Therapy
Faustino, C., & Pinheiro, L. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12010029 · Cited by 203
Mutations in TAC1B : a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris
Rybak, J. M., Muñoz, J. F., Barker, K. S., Parker, J. E., Esquivel, B. D., Berkow, E. L., Lockhart, S. R., Gade, L., Palmer, G. E., White, T. C., et al. (2020) · mBio · doi:10.1128/mbio.00365-20 · Cited by 202
“albicans isolate with pan-triazole resistance and harboring mutations in both CaERG11 and CaERG5 was found to produce no detectable ergosterol while instead accumulating a large amount of ergosta-5,7-dienol (82% of total sterols) (33).”
Self-citationAntifungals: Mechanism of Action and Drug Resistance
Prasad, R., Shah, A. H., & Rawal, M. K. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-25304-6_14 · Cited by 183
Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus
Gonçalves, S. S., Souza, A. C. R., Chowdhary, A., Meis, J. F., & Colombo, A. L. (2016) · Mycoses · doi:10.1111/myc.12469 · Cited by 180
Radhakrishnan, V. S., Reddy Mudiam, M. K., Kumar, M., Dwivedi, S. P., Singh, S. P., & Prasad, T. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s150648 · Cited by 179
Warrilow, A. G. S., Hull, C. M., Parker, J. E., Garvey, E. P., Hoekstra, W. J., Moore, W. R., Schotzinger, R. J., Kelly, D. E., & Kelly, S. L. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03707-14 · Cited by 173
Self-citationUpdate on Candida krusei , a potential multidrug-resistant pathogen
Jamiu, A. T., Albertyn, J., Sebolai, O. M., & Pohl, C. H. (2020) · Medical Mycology · doi:10.1093/mmy/myaa031 · Cited by 212
Identification and Characterization of Four Azole-Resistant erg3 Mutants of Candida albicans
Martel, C. M., Parker, J. E., Bader, O., Weig, M., Gross, U., Warrilow, A. G. S., Rolley, N., Kelly, D. E., & Kelly, S. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00348-10 · Cited by 168
Self-citationA comprehensive overview of the medicinal chemistry of antifungal drugs: perspectives and promise
Howard, K. C., Dennis, E. K., Watt, D. S., & Garneau-Tsodikova, S. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00556k · Cited by 140
Branco, J., Miranda, I. M., & Rodrigues, A. G. (2023) · Journal of Fungi · doi:10.3390/jof9010080 · Cited by 165
Activity and Mechanism of Action of Antifungal Peptides from Microorganisms: A Review
Li, T., Li, L., Du, F., Sun, L., Shi, J., Long, M., & Chen, Z. (2021) · Molecules · doi:10.3390/molecules26113438 · Cited by 151
Lv, Q.-Z., Yan, L., & Jiang, Y.-Y. (2016) · Virulence · doi:10.1080/21505594.2016.1188236 · Cited by 133
Lestner, J., & Hope, W. W. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.794785 · Cited by 128
“Recently, identified additional resistance mechanisms include induction of the alternative respiratory pathways, transporter genes that may affect drug efflux, transcriptional regulation of sterol biosynthesis genes and mutation in sterol-C5-desaturase (required for sterol synthesis) [38-41].”
BackgroundMolecular Mechanisms of Drug Resistance in Clinical Candida Species Isolated from Tunisian Hospitals
Eddouzi, J., Parker, J. E., Vale-Silva, L. A., Coste, A., Ischer, F., Kelly, S., Manai, M., & Sanglard, D. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00555-13 · Cited by 128
Self-citationMorio, F., Pagniez, F., Lacroix, C., Miegeville, M., & Le Pape, P. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks186 · Cited by 120
Dai, T., de Arce, V. J. B., Tegos, G. P., & Hamblin, M. R. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05404-11 · Cited by 115
Molecular basis of antifungal drug resistance in yeasts
Morio, F., Jensen, R. H., Le Pape, P., & Arendrup, M. C. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.05.012 · Cited by 114
Rybak, J. M., Cuomo, C. A., & David Rogers, P. (2022) · Current Opinion in Microbiology · doi:10.1016/j.mib.2022.102208 · Cited by 113
Hull, C. M., Parker, J. E., Bader, O., Weig, M., Gross, U., Warrilow, A. G. S., Kelly, D. E., & Kelly, S. L. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06253-11 · Cited by 113
“used in this study are ergosta 7,22-dienol (7,22), ergosterol (ERG), lanos-”
MethodSelf-citationYadav, A., Singh, A., Wang, Y., Haren, M. H. V., Singh, A., de Groot, T., Meis, J. F., Xu, J., & Chowdhary, A. (2021) · Journal of Fungi · doi:10.3390/jof7020081 · Cited by 111
Treatment of Invasive Candidiasis: A Narrative Review
Ben-Ami, R. (2018) · Journal of Fungi · doi:10.3390/jof4030097 · Cited by 111
Resistance to Antifungal Drugs
Ben‐Ami, R., & Kontoyiannis, D. P. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.003 · Cited by 122
Fungal Drug Response and Antimicrobial Resistance
Osset-Trénor, P., Pascual‐Ahuir, A., & Proft, M. (2023) · Journal of Fungi · doi:10.3390/jof9050565 · Cited by 119
Nishimoto, A. T., Sharma, C., & Rogers, P. D. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz400 · Cited by 102
Hull, C. M., Bader, O., Parker, J. E., Weig, M., Gross, U., Warrilow, A. G. S., Kelly, D. E., & Kelly, S. L. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01145-12 · Cited by 90
Self-citationGarcia, M. D., Chua, S. M. H., Low, Y. S., Lee, Y., Agnew‐Francis, K. A., Wang, J., Nouwens, A. S., Lonhienne, T. G. A., Williams, C. M., Fraser, J. A., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809422115 · Cited by 86
Elias, R., Benhamou, R. I., Jaber, Q. Z., Dorot, O., Zada, S. L., Oved, K., Pichinuk, E., & Fridman, M. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.07.003 · Cited by 78
Aspergillus terreus: Novel lessons learned on amphotericin B resistance
Posch, W., Blatzer, M., Wilflingseder, D., & Lass‐Flörl, C. (2018) · Medical Mycology · doi:10.1093/mmy/myx119 · Cited by 83
Rodrigues, G. B., Dias‐Baruffi, M., Holman, N., Wainwright, M., & Braga, G. Ú. L. (2012) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2012.11.004 · Cited by 77
Levitt, B. B., Lai, H. C., & Manville, A. M. (2021) · Reviews on Environmental Health · doi:10.1515/reveh-2021-0050 · Cited by 79
Sphingolipid Biosynthetic Pathway Genes FEN1 and SUR4 Modulate Amphotericin B Resistance
Sharma, S., Alfatah, Bari, V. K., Rawal, Y., Paul, S., & Ganesan, K. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02130-13 · Cited by 66
Sterol 14α-demethylase mutation leads to amphotericin B resistance in Leishmania mexicana
Mwenechanya, R., Kovářová, J., Dickens, N. J., Mudaliar, M., Herzyk, P., Vincent, I. M., Weidt, S. K., Burgess, K. E., Burchmore, R., Pountain, A. W., et al. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005649 · Cited by 79
Suchodolski, J., Muraszko, J., Bernat, P., & Krasowska, A. (2019) · Microorganisms · doi:10.3390/microorganisms7100378 · Cited by 68
“Blocking the synthesis of ergosterol by inhibition of the Erg11p results in the accumulation of lanosterol, which is converted by ∆(24)-sterol C-methyltransferase (Erg6p) into eburicol, then by Δ5,6-desaturase (Erg3p) into 14α methylergosta-8-24(28)dienol [26].”
BackgroundComparative Genomics for the Elucidation of Multidrug Resistance in Candida lusitaniae
Kannan, A., Asner, S. A., Trachsel, E., Kelly, S., Parker, J., & Sanglard, D. (2019) · mBio · doi:10.1128/mbio.02512-19 · Cited by 63
“albicans for functional ERG11 point mutations combined with defects in ERG5 or ERG3 leading to both azole and AmB resistance (35, 39).”
BackgroundSelf-citationErgosterol Biosynthesis and Regulation Impact the Antifungal Resistance and Virulence of Candida spp
Eliaš, D., Tóth Hervay, N., & Gbelská, Y. (2024) · Stresses · doi:10.3390/stresses4040041 · Cited by 63
“The role of the C. albicans CaERG5 and CaERG4 genes in the resistance of clinical isolates to azoles and amphotericin B has also been assessed [36,50].”
InfluentialAntifungal drug resistance in Candida: a special emphasis on amphotericin B
Ahmady, L., Gothwal, M., Mukkoli, M. M., & Bari, V. K. (2024) · Apmis · doi:10.1111/apm.13389 · Cited by 65
Alpizar-Sosa, E. A., Ithnin, N. R., Wei, W., Pountain, A. W., Weidt, S. K., Donachie, A. M., Ritchie, R., Dickie, E. A., Burchmore, R., Denny, P. W., et al. (2022) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0010779 · Cited by 67
Salazar, S. B., Simões, R., Pedro, N. A., Pinheiro, M. J. F., Carvalho, M. F. N. N., & Mira, N. P. (2020) · Journal of Fungi · doi:10.3390/jof6010023 · Cited by 63
Abid, F. B., Salah, H., Sundararaju, S., Dalil, L., Abdelwahab, A. H., Salameh, S., Ibrahim, E. B., Almaslmani, M. A., Tang, P., Pérez‐López, A., et al. (2023) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2023.04.025 · Cited by 59
Warrilow, A. G. S., Hull, C. M., Rolley, N. J., Parker, J. E., Nes, W. D., Smith, S. N., Kelly, D. E., & Kelly, S. L. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.01195-14 · Cited by 61
Self-citationPais, P., Galocha, M., Viana, R., Cavalheiro, M., Pereira, D., & Teixeira, M. C. (2019) · Microbial Cell · doi:10.15698/mic2019.03.670 · Cited by 51
“It is thought that a decrease in the levels of ergosterol in the cell membrane is connected to the resistant phenotype [70, 71].”
BackgroundSavage, K. A., Parquet, M. D. C., Allan, D. S., Davidson, R. J., Holbein, B. E., Lilly, E. A., & Fidel, P. L. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02576-17 · Cited by 53
An Antifungal Benzimidazole Derivative Inhibits Ergosterol Biosynthesis and Reveals Novel Sterols
Keller, P., Müller, C., Engelhardt, I., Hiller, E., Lemuth, K., Eickhoff, H., Wiesmüller, K.-H., Burger-Kentischer, A., Bracher, F., & Rupp, S. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00640-15 · Cited by 50
“14Methylergosta-8,24(28)-dien-3 ,6 -diol has been reported as fungistatic (35).”
BackgroundMartel, C. M., Parker, J. E., Warrilow, A. G. S., Rolley, N. J., Kelly, S. L., & Kelly, D. E. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00349-10 · Cited by 45
“The sterol composition of YUG37-pcyp51A, YUG37-pcyp51B, and YUG37-pCTRL constructs cultured using gal/rafYM medium (Table 1) was determined by gas chromatography mass spectrometry (GC-MS) as previously described (23).”
MethodSelf-citationSuchodolski, J., Muraszko, J., Korba, A., Bernat, P., & Krasowska, A. (2019) · Yeast · doi:10.1002/yea.3455 · Cited by 47
“Martel et al. (2010) reported previously that blocking the activity of lanosterol 14α-demethylase (Erg11p) resulted in accumulation of lanosterol and its methylated derivatives.”
BackgroundArastehfar, A., Kargar, M. L., Mohammadi, S. R., Roudbary, M., Ghods, N., Haghighi, L., Daneshnia, F., Tavakoli, M., Jafarzadeh, J., Hedayati, M. T., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.655069 · Cited by 41
Insights into the role of sterol metabolism in antifungal drug resistance: a mini-review
Tanwar, S., Kalra, S., & Bari, V. K. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1409085 · Cited by 47
Emerging Mechanisms of Drug Resistance in Candida albicans
Prasad, R., Nair, R., & Banerjee, A. (2019) · Progress in molecular and subcellular biology · doi:10.1007/978-3-030-13035-0_6 · Cited by 45
Photodynamic Antifungal Activity of Hypocrellin A Against Candida albicans
Yang, Y., Wang, C., Zhuge, Y., Zhang, J., Xu, K., Zhang, Q., Zhang, H., Chen, H., Chu, M., & Jia, C. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01810 · Cited by 44
“However, the resistance of C. albicans to clotrimazole has been reported (Martel et al., 2010), and the incidence of resistance to antifungal drugs may be increasing (Fischer et al., 2010).”
BackgroundBojsen, R., Regenberg, B., Gresham, D., & Folkesson, A. (2016) · Scientific Reports · doi:10.1038/srep21874 · Cited by 42
A synthetic peptide mimic kills Candida albicans and synergistically prevents infection
Schaefer, S., Vij, R., Sprague, J. L., Austermeier, S., Dinh, H., Judzewitsch, P. R., Müller‐Loennies, S., Silva, T. L., Seemann, E. A., Qualmann, B., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50491-x · Cited by 45
“The strains are also azole-resistant, which has been attributed to increased drug ef fl ux at least in strain EU0108 35,36 .”
Analysis of Hypoxia and Hypoxia-Like States through Metabolite Profiling
Gleason, J. E., Corrigan, D., Cox, J. E., Reddi, A. R., McGinnis, L. A., & Culotta, V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024741 · Cited by 47
Fluconazole-COX Inhibitor Hybrids: A Dual-Acting Class of Antifungal Azoles
Elias, R., Basu, P., & Fridman, M. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01807 · Cited by 41
Dissecting cholesterol and phytosterol biosynthesis via mutants and inhibitors
Vriese, K. D., Pollier, J., Goossens, A., Beeckman, T., & Vanneste, S. (2020) · Journal of Experimental Botany · doi:10.1093/jxb/eraa429 · Cited by 39
Sun, X., Wang, W., Wang, K., Yu, X., Liu, J., Zhou, F., Xie, B., & Li, S. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00127 · Cited by 37
“ORIGINAL RESEARCH ARTICLE published: 29 May 2013 doi: 10.3389/fmicb.2013.00127 Sterol C-22 desaturase ERG5 mediates the sensitivity to antifungal azoles in Neurospora crassa and Fusarium verticillioides”
BackgroundInfluentialXu, Y., Sheng, F., Zhao, J., Chen, L., & Li, C. (2015) · Archives of Microbiology · doi:10.1007/s00203-015-1146-8 · Cited by 39
Li, Y., Chang, W., Zhang, M., Li, X., Jiao, Y., & Lou, H. (2015) · FEMS Yeast Research · doi:10.1093/femsyr/fov001 · Cited by 36
The effects of photodynamic treatment with new methylene blue N on the Candida albicans proteome
Brancini, G. T. P., Rodrigues, G. B., Rambaldi, M. D. S. L., Izumi, C., Yatsuda, A. P., Wainwright, M., Rosa, J. C., & Braga, G. Ú. L. (2016) · Photochemical & Photobiological Sciences · doi:10.1039/c6pp00257a · Cited by 35
Hull, C. M., Loveridge, E. J., Rolley, N. J., Donnison, I. S., Kelly, S. L., & Kelly, D. E. (2014) · Biotechnology for Biofuels · doi:10.1186/s13068-014-0133-7 · Cited by 33
“Extracts were evaporated to dryness using a centrifugal evaporator (Heto Maxi dry plus) and derivatised using 100 μL N,O-bis(trimethylsilyl)trifluoroacetamide and trimethylchlorosilane (BSTFA-TMCS [99:1]) and 50 μL anhydrous pyridine at 70°C for 2 h [43].”
MethodSelf-citationResistance to antifungal therapies
Prasad, R., Banerjee, A., & Shah, A. H. (2017) · Essays in Biochemistry · doi:10.1042/ebc20160067 · Cited by 37
Hull, C. M., Warrilow, A. G. S., Rolley, N. J., Price, C. L., Donnison, I. S., Kelly, D. E., & Kelly, S. L. (2017) · Biotechnology for Biofuels · doi:10.1186/s13068-017-0904-z · Cited by 33
“metabolite analysis Prior to GC–MS analysis, steroid extracts were heated (70 °C, 10 min) to ensure complete dryness and derivatized using 100 μL N,O-bis(trimethylsilyl)trifluoroacetamide-trimethylchlorosilane (BSTFA-TMCS [99:1]) and 100 μL anhydrous pyridine heated at 70 °C for 2 h [41].”
MethodSelf-citationBeyond Conventional Antifungals: Combating Resistance Through Novel Therapeutic Pathways
Hetta, H. F., Melhem, T., Aljohani, H. M., Salama, A., Ahmed, R., Elfadil, H., Alanazi, F. E., Ramadan, Y. N., Battah, B., Rottura, M., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18030364 · Cited by 35
“In C. albicans , the depletion of ergosterol in the cell membrane causes the substitution of ergosterol with other sterol intermediates, and this also accounts for cross-resistance to azoles and AmB [133,134].”
Sedaxicenes: potential new antifungal ferrocene-based agents?
Rubbiani, R., Blacque, O., & Gasser, G. (2016) · Dalton Transactions · doi:10.1039/c5dt04231c · Cited by 32
Hlavica, P. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2012.09.012 · Cited by 31
“Of note, CYP61A2 from Candida albicans, sharing 70% sequence identity with CYP61A1, prefers ergosta-5,7,24(28)-trienol as the natural substrate to produce ergosta5,7,22,24(28)-tetraenol [100].”
BackgroundInsights into the Multi-Azole Resistance Profile in Candida haemulonii Species Complex
Silva, L. N., Ramos, L. S., de Oliveira, S. S. C., Magalhães, L. B., Squizani, E. D., Kmetzsch, L., Vainstein, M. H., Branquinha, M. H., & dos Santos, A. L. S. (2020) · Journal of Fungi · doi:10.3390/jof6040215 · Cited by 27
Dalhoff, A. (2017) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2017.10.024 · Cited by 32
Müller, C., Neugebauer, T., Zill, P., Lass‐Flörl, C., Bracher, F., & Binder, U. (2018) · Molecules · doi:10.3390/molecules23051218 · Cited by 28
“Accumulation of this toxic intermediate [28,29,46] under the inhibition of sterol C14-demethylase was only detected in yeasts so far, but not in A.”
BackgroundRecent Advances in Genome Editing Tools in Medical Mycology Research
Nargesi, S., Kaboli, S., Thekkiniath, J., Heidari, S., Keramati, F., Seyedmousavi, S., & Hedayati, M. T. (2021) · Journal of Fungi · doi:10.3390/jof7040257 · Cited by 25
Gong, J., Chen, X.-F., Fan, X., Xu, J., Zhang, H., Li, R., Chen, S. C. ‐., Kong, F., Zhang, S., Sun, Z., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03807-22 · Cited by 26
Hu, L., Du, X., Li, T., Song, Y. J., Zai, S., Hu, X., Zhang, X., & Li, M. (2014) · Journal of Medical Microbiology · doi:10.1099/jmm.0.080200-0 · Cited by 26
“It is possible that other genes, such as ERG5 and ERG3, contribute to azole resistance (Martel et al., 2010a, 2010b), which deserves further investigation.”
BackgroundEnhanced topical econazole antifungal efficacy by amine-functionalized silica nanoparticles
Montazeri, M., Razzaghi‐Abyaneh, M., Nasrollahi, S. A., Maibach, H. I., & Nafisi, S. (2019) · Bulletin of Materials Science · doi:10.1007/s12034-019-1974-2 · Cited by 23
Arendrup, M. C., Lockhart, S. R., & Wiederhold, N. P. (2024) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2024.10.010 · Cited by 22
“Amphotericin B resistance in Candida spp. has been associated with mutations in erg2 [18,19] and erg6 [20] and with combined mutations in erg11 and in erg3 or erg5 [18–22].”
Genomic Variation-Mediating Fluconazole Resistance in Yeast
Wang, W., Cai, H., Qu, S.-Y., Lin, W., Liang, C., Liu, H., Xie, Z., & Yuan, Y. (2022) · Biomolecules · doi:10.3390/biom12060845 · Cited by 22
“In addition, clinical Candida isolates with ERG5 and ERG11 mutations exhibit a complete reduction in ergosterol and a cross-resistance to fluconazole and amphotericin B (AmB) (Figure 1A) [10].”
BackgroundSmall molecules restore azole activity against drug-tolerant and drug-resistant Candida isolates
Alabi, P., Gautier, C., Murphy, T. P., Gu, X., Lepas, M., Aimanianda, V., Sello, J. K., & Ene, I. V. (2023) · mBio · doi:10.1128/mbio.00479-23 · Cited by 30
Binder, U., Aigner, M., Risslegger, B., Hörtnagl, C., Lass‐Flörl, C., & Lackner, M. (2019) · Journal of Fungi · doi:10.3390/jof5030083 · Cited by 24
Żak, I., Jagielski, T., Kwiatkowski, S., & Bielecki, J. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.06.015 · Cited by 22
Kang, C.-K., Yamada, K., Usuki, Y., Ogita, A., Fujita, K., & Tanaka, T. (2013) · Microbiology · doi:10.1099/mic.0.065714-0 · Cited by 21
“The AmB-resistant phenotype has appeared in various pathogenic fungi because of a mutation in the gene encoding one of the ergosterol biosynthetic enzymes (Martel et al., 2010; Sanglard et al., 2003; Young et al., 2003).”
BackgroundAntifungal resistance, combinations and pipeline: oh my!
Stover, K. R., Hawkins, B. K., Keck, J. M., Barber, K. E., & Cretella, D. A. (2023) · Drugs in Context · doi:10.7573/dic.2023-7-1 · Cited by 22
“57,60,65 Similar substitution effects have also been observed with C. glabrata and Candida lusitaniae , though resulting from ERG6 and ERG2 mutations.”
ResultBrilhante, R. S., Pereira, V. S., de Oliveira, J. S., Lopes, R. G. P., Rodrigues, A. M., Camargo, Z. P. D., Pereira‐Neto, W. D. A., Castelo‐Branco, D. D. S. C. M., Cordeiro, R. D. A., Sidrim, J. J. C., et al. (2018) · Future Microbiology · doi:10.2217/fmb-2018-0070 · Cited by 18
Lim, H. J., Choi, M. J., Byun, S. A., Won, E. J., Park, J.-H., Choi, Y. J., Choi, H., Choi, H.-W., Kee, S., Kim, S. H., et al. (2023) · Journal of Fungi · doi:10.3390/jof9050515 · Cited by 19
Triclosan Antagonizes Fluconazole Activity against Candida albicans
Higgins, J., Pinjon, E., Oltean, H. N., White, T. C., Kelly, S. L., Martel, C. M., Sullivan, D. J., Coleman, D. C., & Moran, G. P. (2011) · Journal of Dental Research · doi:10.1177/0022034511425046 · Cited by 23
Self-citationHsp90 interaction networks in fungi—tools and techniques
Crunden, J. L., & Diezmann, S. (2021) · FEMS Yeast Research · doi:10.1093/femsyr/foab054 · Cited by 18
“The strain was reported to be resistant against the most commonly deployed class of antifungals, the azoles and the lastline antimycotic Amphotericin B, severely compromising the antifungal armamentarium available to treat this patient (Martel et al. 2010).”
Huang, C.-Y., Chen, Y., Wu‐Hsieh, B. A., Fang, J., & Chang, Z.-F. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006798 · Cited by 16
Lanna, M., Lovatto, J. E., de Almeida, J. N., Medeiros, E. A., Colombo, A. L., & García‐Effrón, G. (2025) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2025.101546 · Cited by 16
Zaccaron, A. Z., Neill, T. M., Corcoran, J. A., Mahaffee, W. F., & Stergiopoulos, I. (2023) · mBio · doi:10.1128/mbio.00645-23 · Cited by 22
Deng, L., Zou, L., Wu, J., Liu, H., Luo, T., Zhou, X., Li, W., & Ren, B. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.02.010 · Cited by 17
Molecular Mechanisms of Resistance to Antifungals in Candida albicans
Ruiz‐Baca, E., Arredondo-Sánchez, R. I., Corral-Pérez, K., López-Rodríguez, A., Meneses‐Morales, I., Ayala‐García, V. M., & Martínez-Rocha, A. L. (2021) · Infectious diseases · doi:10.5772/intechopen.96346 · Cited by 23
“CA12 contains a substitution (W332R) in ERG3 and no residue changes in ERG11.”
InfluentialNim, S., Rawal, M. K., & Prasad, R. (2014) · FEMS Yeast Research · doi:10.1111/1567-1364.12149 · Cited by 14
Identification of 14-α-Lanosterol Demethylase (CYP51) in Scedosporium Species
Bernhardt, A., Meyer, W., Rickerts, V., Aebischer, T., & Tintelnot, K. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02599-17 · Cited by 14
“The inhibition of ERG11/CYP51 results in cell membrane stress, which is caused by the decrease in ergosterol, an accumulation of lanosterol, and other toxic sterol intermediates (18, 19).”
BackgroundMüller, C., Binder, U., Maurer, E., Grimm, C. M., Giera, M. A., & Bracher, F. (2015) · Steroids · doi:10.1016/j.steroids.2015.05.004 · Cited by 14
Caban, M., Strapagiel, D., Dziadek, J., Korycka‐Machała, M., & Grzelak, A. (2016) · Current Microbiology · doi:10.1007/s00284-016-1039-3 · Cited by 14
Metadata
- Authors
- Martel, C. M., Parker, J. E., Bader, O., Weig, M., Gross, U., Warrilow, A. G. S., Kelly, D. E., & Kelly, S. L.
- Affiliations
- Swansea University (GB)
- Universitätsmedizin Göttingen (DE)
- ORCID
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2010-09
- Volume
- 54
- Issue
- 9
- Pages
- 3578-3583
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC2934972
- OpenAlex
- W2162351832
- Cited by
- 165
- References
- 37
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 14 · 2023: 14 · 2022: 9 · 2021: 12 · 2020: 10 · 2019: 18 · 2018: 15 · 2017: 10 · 2016: 9 · 2015: 6 · 2014: 11 · 2013: 6 · 2012: 7
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- GRO (submittedVersion, cc-by)
- Funders
- Engineering and Physical Sciences Research Council
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- Candida albicans, azole resistance, amphotericin B resistance, ERG11, sterol 14α-demethylase, fluconazole, voriconazole, ketoconazole, clotrimazole, itraconazole, multidrug efflux pumps, tacrolimus, FK506, clinical isolates, double mutants
- MeSH terms
- Amphotericin B, Antifungal Agents, Azoles, Candida albicans, Fungal Proteins, Microbial Sensitivity Tests, Mutation, Polymerase Chain Reaction, Drug Resistance, Fungal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.